Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR

View ORCID ProfileMichael Huber, View ORCID ProfilePeter W. Schreiber, View ORCID ProfileThomas Scheier, View ORCID ProfileAnnette Audigé, Roberto Buonomano, View ORCID ProfileAlain Rudiger, View ORCID ProfileDominique L. Braun, View ORCID ProfileGerhard Eich, View ORCID ProfileDagmar Keller, View ORCID ProfileBarbara Hasse, View ORCID ProfileChristoph Berger, View ORCID ProfileAmapola Manrique, View ORCID ProfileHuldrych F. Günthard, Jürg Böni, View ORCID ProfileAlexandra Trkola
doi: https://doi.org/10.1101/2020.12.01.20241778
Michael Huber
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Huber
Peter W. Schreiber
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter W. Schreiber
Thomas Scheier
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Scheier
Annette Audigé
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annette Audigé
Roberto Buonomano
3Division of Infectious Diseases and Hospital Hygiene, Spital Limmattal, Schlieren, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Rudiger
4Division of Medicine, Spital Limmattal, Schlieren, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alain Rudiger
Dominique L. Braun
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dominique L. Braun
Gerhard Eich
5Division of Infectious Diseases, Hospital Hygiene and Occupational Medicine, Stadtspital Triemli, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerhard Eich
Dagmar Keller
6Emergency Unit, University Hospital Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dagmar Keller
Barbara Hasse
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara Hasse
Christoph Berger
7Division of Infectious Diseases and Hospital Epidemiology, University Children’s Hospital Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christoph Berger
Amapola Manrique
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amapola Manrique
Huldrych F. Günthard
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
2Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Huldrych F. Günthard
Jürg Böni
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Trkola
1Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandra Trkola
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background A high volume of testing followed by rapid isolation and quarantine measures is critical to the containment of SARS-CoV-2. RT-PCR of nasopharyngeal swabs (NPS) has been established as sensitive gold standard for the detection of SARS-CoV-2 infection. Yet, additional test strategies are in demand to increase and broaden testing opportunities. As one attractive option, saliva has been discussed as an alternative to NPS as its collection is simple, non-invasive, suited for children and amenable for mass- and home-testing.

Methods Here, we report on the outcome of a head-to-head comparison of SARS-CoV-2 detection by RT-PCR in saliva and nasopharyngeal swab (NPS) of 1187 adults and children reporting to outpatient test centers and an emergency unit for an initial SARS-CoV-2 screen.

Results In total, 252 individuals were tested SARS-CoV-2 positive in either NPS or saliva. SARS-CoV-2 RT-PCR results in the two specimens showed a high agreement (Overall Percent Agreement = 98.0%). Despite lower viral loads in saliva, we observed sensitive detection of SARS-CoV-2 in saliva up to a threshold of Ct 33 in the corresponding NPS (Positive Percent Agreement = 97.7%). In patients with Ct above 33 in NPS, agreement rate dropped but still reaches notable 55.9%.

Conclusion The comprehensive parallel analysis of NPS and saliva reported here establishes saliva as a reliable specimen for the detection of SARS-CoV-2 that can be readily added to the diagnostic portfolio to increase and facilitate testing.

Key points Comparison with nasopharyngeal swabs in a large test center-based study shows that saliva is a reliable and convenient material for the detection of SARS-CoV-2 by RT-PCR in adults and children.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants of the Swiss federal office of public health (FOPH) and the University of Zurich Foundation to A.T. Roche Diagnostics supported the study with PCR kits and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Zurich Cantonal Ethics Commission waived the necessity for a formal ethical evaluation based on the Swiss law on research on human subjects, as the collection of saliva in parallel to a scheduled nasopharyngeal swab induces no risk and no additional personal data beyond the usual information on symptoms and duration required by the FOPH for all SARS-CoV-2 tests in Switzerland was collected (Req-2020-00398).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript are available from the corresponding author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted December 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR
Michael Huber, Peter W. Schreiber, Thomas Scheier, Annette Audigé, Roberto Buonomano, Alain Rudiger, Dominique L. Braun, Gerhard Eich, Dagmar Keller, Barbara Hasse, Christoph Berger, Amapola Manrique, Huldrych F. Günthard, Jürg Böni, Alexandra Trkola
medRxiv 2020.12.01.20241778; doi: https://doi.org/10.1101/2020.12.01.20241778
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR
Michael Huber, Peter W. Schreiber, Thomas Scheier, Annette Audigé, Roberto Buonomano, Alain Rudiger, Dominique L. Braun, Gerhard Eich, Dagmar Keller, Barbara Hasse, Christoph Berger, Amapola Manrique, Huldrych F. Günthard, Jürg Böni, Alexandra Trkola
medRxiv 2020.12.01.20241778; doi: https://doi.org/10.1101/2020.12.01.20241778

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (420)
  • Anesthesia (97)
  • Cardiovascular Medicine (896)
  • Dentistry and Oral Medicine (169)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (405)
  • Epidemiology (8764)
  • Forensic Medicine (4)
  • Gastroenterology (404)
  • Genetic and Genomic Medicine (1857)
  • Geriatric Medicine (177)
  • Health Economics (387)
  • Health Informatics (1284)
  • Health Policy (642)
  • Health Systems and Quality Improvement (490)
  • Hematology (206)
  • HIV/AIDS (392)
  • Infectious Diseases (except HIV/AIDS) (10543)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1748)
  • Nursing (102)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (459)
  • Oncology (962)
  • Ophthalmology (281)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1841)
  • Public and Global Health (3975)
  • Radiology and Imaging (650)
  • Rehabilitation Medicine and Physical Therapy (341)
  • Respiratory Medicine (534)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (79)